X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
female (31) 31
male (30) 30
adult (26) 26
dermatology (24) 24
middle aged (22) 22
index medicus (21) 21
atopic dermatitis (16) 16
treatment outcome (14) 14
japan (12) 12
animals (11) 11
psoriasis (11) 11
psoriasis - drug therapy (9) 9
adolescent (8) 8
analysis (8) 8
severity of illness index (8) 8
aged (7) 7
calculating (7) 7
care and treatment (7) 7
computing (7) 7
counting (7) 7
dermatitis (7) 7
expression (7) 7
handling record carriers (7) 7
physics (7) 7
presentation of data (7) 7
recognition of data (7) 7
record carriers (7) 7
child (6) 6
pharmaceutical industry (6) 6
rheumatoid-arthritis (6) 6
adalimumab (5) 5
alleles (5) 5
allergy (5) 5
arthritis (5) 5
clinical trials (5) 5
dermatitis, atopic - drug therapy (5) 5
dermatitis, atopic - genetics (5) 5
dermatologic agents - adverse effects (5) 5
disease (5) 5
double-blind (5) 5
eczema (5) 5
hla (5) 5
immunology (5) 5
infliximab (5) 5
molecular sequence data (5) 5
monoclonal antibodies (5) 5
original (5) 5
original article (5) 5
patients (5) 5
polymerase chain reaction (5) 5
quality of life (5) 5
safety (5) 5
therapy (5) 5
tumor cells, cultured (5) 5
base sequence (4) 4
biochemistry (4) 4
cell biology (4) 4
corticosteroids (4) 4
dermatitis, atopic - immunology (4) 4
double-blind method (4) 4
further section (4) 4
genetic research (4) 4
genotype (4) 4
guidelines (4) 4
japanese (4) 4
management (4) 4
medical colleges (4) 4
mice (4) 4
molecular biology (4) 4
ointments (4) 4
original articles (4) 4
prescription drugs (4) 4
pruritus (4) 4
skin (4) 4
abridged index medicus (3) 3
adsorption (3) 3
adults (3) 3
agriculture, dairy & animal science (3) 3
anti-inflammatory agents - administration & dosage (3) 3
anti-inflammatory agents - adverse effects (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antibodies, monoclonal, humanized - adverse effects (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
arthritis, psoriatic - drug therapy (3) 3
beef (3) 3
cattle (3) 3
cell movement - physiology (3) 3
dermatitis, atopic - blood (3) 3
dermatologic agents (3) 3
dermatologic agents - administration & dosage (3) 3
dermatologic agents - therapeutic use (3) 3
dermatology & venereal diseases (3) 3
diagnosis, differential (3) 3
drug therapy (3) 3
drug therapy, combination (3) 3
epinastine (3) 3
fda approval (3) 3
formulae, receipts, prescriptions (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10086, pp. 2287 - 2303
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 10/2016, Volume 43, Issue 10, pp. 1117 - 1145
Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The... 
evidence‐based medicine | clinical practice guideline | treatment | atopic dermatitis | diagnosis | evidence-based medicine | FLUTICASONE PROPIONATE CREAM | CONTROLLED-TRIAL | HOUSE-DUST-MITE | CHINESE HERBAL MEDICINE | 4-YEAR FOLLOW-UP | TACROLIMUS OINTMENT | OF-LIFE MEASURE | ACTIVATION-REGULATED CHEMOKINE | DERMATOLOGY | TOPICAL CORTICOSTEROIDS | DOUBLE-BLIND | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Dermatologic Agents - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Dermatitis, Atopic - classification | Dermatologic Agents - therapeutic use | Administration, Cutaneous | Dermatitis, Atopic - therapy | Histamine Antagonists - therapeutic use | Dermatologic Agents - adverse effects | Histamine Antagonists - adverse effects | Dermatitis, Atopic - diagnosis | Anti-Inflammatory Agents - adverse effects | Pruritus - therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Ointments | Glucocorticoids - adverse effects | Patient Education as Topic | Tacrolimus - administration & dosage | Severity of Illness Index | Administration, Oral | Japan | Histamine Antagonists - administration & dosage | Evidence-Based Medicine | Tacrolimus - adverse effects | Ultraviolet Therapy - methods | Tacrolimus - therapeutic use | Quality of Life | Diet Therapy - methods | Immunosuppressive Agents - adverse effects | Dermatitis, Atopic - blood | Patient Compliance | Usage | Tacrolimus | Dermatology | Atopic dermatitis | Formulae, receipts, prescriptions | Dermatologic agents | Pruritus | Prescription drugs | Clinical medicine | Dermatitis
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 10/2018, Volume 142, Issue 4, pp. 1121 - 1130.e7
Nemolizumab, an anti–IL-31 receptor A mAb, improved pruritus, dermatitis, and sleep in adults with moderate-to-severe atopic dermatitis that was inadequately... 
pruritus | atopic dermatitis | Monoclonal antibody | IL-31 receptor | nemolizumab | IL-31 | PLACEBO | MANAGEMENT | ECZEMA | GUIDELINES | NATIONAL-HEALTH | RECEPTOR | IMMUNOLOGY | INTERLEUKIN-31 | SKIN BARRIER | CARE | ALLERGY | Viral antibodies | Antibodies | Care and treatment | Pruritus | Atopic dermatitis | Analysis | Edema | FDA approval | Dermatitis | Patients | Asthma | Histamine | Randomization | Sleep | Eczema | Monoclonal antibodies | Population | Skin diseases | Skin | Adults | Safety | Drug dosages
Journal Article
Journal Article
Journal Article